Category: Cardiac Implants
SynCardia gains the FDA's O.K. to test its artificial heart as a permanent implant in 19 patients.
SynCardia plans to test its artificial heart as a permanent implant rather than a placeholder for donor transplants in 19 patients.
Sorin Group is beginning a U.S. rollout of a new surgical implant ring for addressing mitral valve repair issues.
Italy's Sorin Group (BIT:SRN) nailed down FDA clearance for a new surgical implant designed for use in mitral valve repair.
An FDA advisory panel's unprecedented 3rd hearing over Boston Scientific's Watchman anti-stroke device barely favors the cardiac implant.
An FDA advisory panel gives a mixed view in its unprecedented 3rd review of Boston Scientific's Watchman anti-stroke device.
The FDA expresses some doubts about new data from Boston Scientific on its Watchman anti-stroke device.
LoneStar Heart wins CE Mark approval in the European Union for its Algisyl-LVR hydrogel implant, a hydrogel implant designed to treat heart failure.
Laguna Hills, Calif.-based LoneStar Heart said it won CE Mark approval in the European Union for its Algisyl-LVR hydrogel implant for the treatment of advanced heart failure.
New data presented last week at the annual Transcatheter Cardiovascular Therapies meeting showed Boston Scienfitic's Watchman anti-stoke device to be comparable to treatment with the anti-coagulant warfarin.